. Introduction
Photothermal therapy in cancer medicine has garnered increasing attention over the past two decades because of the ability to locally ablate disease while leaving surrounding, normal tissue unharmed. [ 1 ] This approach is feasible with the addition of exogenous optical absorbers, which by design are normally benign but strongly absorb specifi c wavelengths of light and subsequently dissipate this energy as heat. Near-infrared (NIR) light in the range of 650-900 nm is ideally suited for this purpose because the major tissue chromophores are minimally absorptive within this spectral region, allowing deep and harmless penetration. [ 2, 3 ] If tissue
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Andrew J. Coughlin , Jeyarama S. Ananta , Nanfu Deng , Irina V. Larina , Paolo Decuzzi , and Jennifer L. West * temperatures on the order of ∼ 50-55 °C are achieved, [ 4 ] irreversible membrane rupturing occurs to elicit cell death. [ 5 ] Furthermore, this heating effect is only realized where light and the optical absorbers are locally combined, thus affording more site-specifi c therapy than standard chemotherapeutic regimens, for instance, which kill both healthy and diseased cells.
To ensure that the entirety of the tumor tissue is irradiated with NIR light, diagnostic imaging technologies can be employed to elucidate the extent of disease spread. Because many of these technologies provide unique perspectives and associated advantages, combining platforms in multimodal diagnostic approaches facilitates more holistic characterization of disease compared to using any one imaging mode alone. [6] [7] [8] For example, anatomic imaging platforms like magnetic resonance (MR) and computed tomography (CT) can be used to initially identify suspicious lesions, while optical modalities can subsequently hone in at the molecular level to enable accurate diagnosis. Then if deemed necessary, photo thermal therapy with optical absorption agents can be applied to locally ablate disease at identifi ed sites of interest.
To facilitate and streamline each of these steps in multimodal image-guided photothermal therapy, multifunctional nanoparticle platforms can be employed. With the administration of a single, appropriately designed nanoparticle agent, imaging contrast enhancement and improved sensitivity can be achieved across modalities along with subsequent absorption of NIR light for thermal destruction of tumor tissue. Herein, we describe gadolinium-conjugated gold-silica nanoshells that function as probes in MRI, X-ray, and optical imaging as well as absorptive agents in photothermal therapy.
These particles contain a specifi c gold-silica shell-core geometry [ 9 ] that exhibits surface plasmon resonance (SPR) and maximum light extinction within the NIR region. Additionally, the gold surface layer affords biocompatibility, [10] [11] [12] facile surface conjugation chemistry via sulfur-gold linkages, and attenuation of X-ray radiation because of its associated high atomic number and electron density. [ 13 ] Previously, light scattering by gold nanoshells was exploited as contrast in a variety of optical imaging applications, including dark fi eld microscopy in vitro, [ 14 ] refl ectance confocal microscopy (RCM) ex vivo, [ 15 ] and optical coherence tomography (OCT) both in vitro [ 16, 17 ] and in vivo. [ 18 ] Light absorption has also been harnessed for two-photon luminescent (TPL) imaging contrast [ 19 ] and photothermal ablation of cancer, [ 20 ] each performed in vitro and in vivo. After particle conjugation to gadolinium, we demonstrate their broad functionality as contrast agents across MRI, X-ray, and three optical imaging methods: OCT, RCM and TPL. We also show significantly improved MRI contrast enhancement effi cacy when gadolinium chelates are conjugated to gold nanoshells. Finally, we confi rm that these particles are efficient photothermal converters and can be employed to ablate cancer cells in vitro.
. Results and Discussion
Gold-silica nanoshells were synthesized according to a four-step procedure as previously described by Oldenburg et al. [ 9 ] After forming a ∼ 16 nm gold shell over ∼ 120 nm silica core nanoparticles, nanoshells displayed an average diameter of 152 ± 10 nm, imaged by transmission electron microscopy (TEM, Figure 1 A and B). Measurements were acquired and tabulated within NIH ImageJ software (n = 215). Additionally, characterization with UV-vis spectroscopy demonstrated nanoshell plasmon resonance and maximum extinction at approximately 800 nm, which is within the biologically relevant NIR water window (Figure 1 C) .
Gadolinium conjugation to gold nanoshells was performed by fi rst employing a heterobifunctional poly(ethylene glycol) (PEG) linker with a succinimidyl proprionate (SPA) end-group for reacting with an aminated Gd(III) chelator and an orthopyridyl disulfi de (OPSS) for eventual adsorption to gold ( Scheme 1 ). Tetraazacyclododecane tetraacetic acid (DOTA) was chosen as the chelator because of the high stability of Gd(DOTA) relative to other cyclic complexes [ 21 ] and the availability of established metalation procedures. [ 22, 23 ] Once synthesis of OPSS-PEG-DOTA was confi rmed with gel permeation chromatography (GPC, Supporting Information Figure 1 . TEM images of gold-silica nanoshells at (A) low and (B) high magnifi cation. Particles displayed an average diameter of 152 ± 10 nm ( n = 215, polydispersity = 6.70%). (C) UV-vis spectroscopy showed maximum extinction within the near-infrared water window, where light has deep penetration into tissue. Scheme 1. Scheme for OPSS-PEG-Gd(DOTA) synthesis and eventual conjugation to nanoshell surfaces. (1) OPSS-PEG-SPA (MW = 2 kDa) was conjugated to an aminated derivative of DOTA, a strong chelator of Gd(III) ions, via an amide bond. (2) Following acid-mediated removal of tertButyl esters, (3) OPSS-PEG-DOTA was mixed with GdCl 3 at basic pH to facilitate chelation. (4) OPSS-PEG-Gd(DOTA) chains were then adsorbed onto gold-silica nanoshell surfaces via goldsulfur interactions, and (5) PEG-SH (MW = 5 kDa) was used to backfi ll remaining gold surface area and promote further stabilization. Abbreviations: OPSS, orthopyridyl disulfi de; PEG, poly(ethylene glycol); SPA, succinimidyl proprionate; DOTA, tetraazacyclododecane tetraacetic acid; DMF, N,N -dimethylformamide; DIPEA, N,N -diisopropylethylamine; TFA, trifl uoroacetic acid; DCM, dichloromethane; GdCl 3 , gadolinium chloride; PEG-SH, poly(ethylene glycol)-thiol. Figure S1 ), a metalation reaction with gadolinium chloride (GdCl 3 ) was conducted to form OPSS-PEG-Gd(DOTA). Additional characterization on OPSS-PEG-DOTA and OPSS-PEG-Gd(DOTA) was perfomed with proton nuclear magnetic resonance (NMR) spectroscopy (Supporting Information, Figure S2 ). The polymer chains with chelated Gd(III) ions were then incubated with gold-silica nanoshells, during which time the chains self-assembled onto the gold surface via sulfur-gold interactions. Remaining gold surface area was backfi lled with PEG-thiol (PEG-SH) to further passivate particle surfaces and enhance stability in suspension. Following particle conjugation, hydrodynamic diameters were observed to increase by ∼ 40% and zeta potential values by ∼ 30% (Supporting Information  Table S1 ).
The degree of gadolinium conjugation was quantitatively evaluated via elemental analysis with inductively coupled plasma mass spectrometry (ICP-MS). After acid mediated digestion of the particles, ICP-MS showed an average of 3.5 ± 0.1 × 10 4 Gd(III) ions/nanoshell ( n = 3). While this analysis was performed on the batch of gadolinium-nanoshells (Gd-NS) used throughout the work presented herein, the chemical conjugation methods were found to be reproducible. Across 12 particle-conjugate batches, the average Gd content was 3.9 ± 0.5 × 10 4 ions/nanoshell, translating to a variability of ∼ 13%. Additionally, nanoshell samples were pelleted by centrifugation, and analysis on the supernatant with ICP-MS revealed that ∼ 99.9% of the total Gd content in the Gd-NS samples was in fact conjugated.
Gadolinium complexes are known to shorten the longitudinal relaxation time ( T 1 ) of water protons because of the metal ion's high magnetic moment and symmetric electronic ground state. [ 21 ] T 1 relaxation times for Gd-NS at various concentrations in water were acquired with a 1.41 T benchtop relaxometer at 37 °C and compared to those of OPSS-PEG-Gd(DOTA) at equivalent gadolinium concentrations and nanoshells conjugated only to PEG-SH (PEG-NS) at equivalent nanoshell concentrations ( n = 6, Figure 2 ). At the highest nanoshell concentrations tested, for instance, Gd-NS exhibited a T 1 relaxation time of 462 ± 2 ms as compared to 3,269 ± 4 ms for PEG-NS and 3,842 ± 2 ms for water alone, indicating that the contribution of the nanoshells themselves to relaxation remains low (Figure 2 B) . This observation is in agreement with previous studies that have shown only nominal relaxation enhancements with gold and silicon nanomaterials without gadolinium content. [ 24, 25 ] Therefore, the gadolinium present on the surfaces of Gd-NS is principally responsible for the observed decreases in relaxation times. Additionally, when comparing OPSS-PEG-Gd(DOTA) and Gd-NS at their highest tested gadolinium concentrations, the PEG linker showed a longer T 1 relaxation time of 1,677 ± 1 ms versus 462 ± 2 ms for Gd-NS (Figure 2 A) . This trend was consistent across all gadolinium concentrations tested. Furthermore, the ability of any material to act as an MRI contrast agent is defi ned in terms of relaxivity, where r 1 relaxivity is defi ned as the change in T 1 relaxation rates of water protons normalized to gadolinium content. The calculated r 1 values of 7 mM This observed enhancement in relaxivity from OPSS-PEG-Gd(DOTA) to Gd-NS is likely a result of the restricted molecular tumbling and therefore increased τ R rotational correlation times of the Gd-chelates after conjugation to nanoshell surfaces. Solomon, Bloembergen, and Morgan have previously described that increases in τ R rotational correlation times result in increased r 1 relaxtivities. [ 21, 26 ] In fact, the r 1 value for Gd-NS is ∼ 9 times higher than that of current, . [ 21, 26 ] Per particle r 1 relaxivity for Gd-NS is 1.31 × 10 6 mM −1 s −1 because of the high density of Gd(III) ions on each nanoshell surface. Other studies have also demonstrated relaxivity enhancements with gadolinium complexes tethered to nanomaterial platforms. For example, Song et al. conjugated Gd-chelates to 30 nm gold nanoparticles via thiol-terminated DNA and achieved an r 1 relaxivity of 20 mM −1 s −1 per Gd at 1.41 T and 37 °C. [ 27 ] Similarly, Morrigi and colleagues enshrouded ∼ 5 nm gold nanoparticles in a rigid layer of directly thiolated Gdchelates and observed an r 1 value of 50 mM −1 s −1 per Gd at 1.41 T and 25 °C. [ 25 ] An evaluation of Gd-NS cytotoxicity was performed using the MTS assay, an established method for determining the effect of nanoparticles on cell metabolic activity and hence viability. [ 28 ] In live cells, mitochondrial dehydrogenase enzymes convert the MTS reagent (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) to a formazan product detectable via absorbance measurements. Both hepatocellular carcinoma HepG2 cells and human dermal fi broblasts (HDF's) were employed, both common cell types for characterizing nanoparticle toxicity. [ 28 ] Nanoparticle concentrations spanning 0 to 15 000 particles/cell were tested, a range which includes previously reported and anticipated exposure levels of 1-100 particles/cell for nano-sized systems in vivo. [ 29, 30 ] Both Gd-NS and PEG-NS were incubated with HepG2 and HDF cells for 24 and 48 h, at which times the MTS assay was performed. Across all particle concentrations tested for both time points, no statistically signifi cant decrease in cell viability was observed, demonstrating suitable biocompatibility of the nanoshell conjugates ( Figure 3 ).
Next, Gd-NS were encapsulated in 1% agarose at a concentration of 4.2 × 10 11 particles/mL and exhibited strong positive contrast compared to agarose-only control phantoms across fi ve diagnostic imaging modalities: T 1 -weighted magnetic resonance imaging (MRI, Philips Ingenia 3 T with an inversion recovery pulse sequence), X-Ray (Kubtec XPERT80), optical coherence tomography (OCT, Nirus Imalux 1310), refl ectance confocal microscopy (RCM, VivaScope 2500), and two-photon luminescence (TPL, Zeiss Laser Scanning Microscope 510) ( Figure 4 ). With MR and X-ray imaging, the entirety of the phantom could be imaged at the macroscale within a single acquisition. Furthermore with optical modalities such as OCT and RCM, imaging across tens to hundreds of microns was feasible. Finally TPL facilitated even higher resolution imaging where individual particles could be resolved at high (63×) magnifi cation. By comparison, phantoms loaded with PEG-NS demonstrated no contrast under MR as expected, considering the relatively small reductions in T 1 times for PEG-NS observed during relaxometry characterization. However, PEG-NS exhibited signal intensity levels similar to that of Gd-NS across all other modalities because of near identical spectral properties between the two particle types.
In addition to their utility as diagnostic contrast agents, Gd-NS are effi cient absorbers of NIR light, whereupon this energy is converted to heat that can be employed to locally ablate cancer tissue. To evaluate the potential for Gd-NS to be used in photothermal cancer therapy, a photothermal conversion study was performed. Particles were suspended in water ( n = 3) at three optical densities (OD 800 = 1, 2, and 4 corresponding to 0.25, 0.5, and 1.0 × 10 10 particles/mL) and then irradiated at 808 nm for 3 min at three laser power settings (1.25, 2.5 and 5 W). Both PEG-NS and water were also irradiated for comparison. Temperature readings acquired with a thermocouple indicated that Gd-NS and PEG-NS suspensions heated to higher temperatures with increasing particle concentrations and higher laser powers ( Figure 5 ). No statistical difference was found in the maximum temperatures recorded for Gd-NS and PEG-NS at any given particle concentration and laser power combination, indicating that the presence of the gadolinium on the exterior of the nanoshell does not inhibit photothermal conversion. In contrast, water controls without nanoshells exhibited minimal heating above room temperature across all laser powers tested.
The ability of Gd-NS to convert NIR light to heat also enabled ablation of cancer cells ( Figure 6 ). The particles were incubated with B16-F10 melanoma cells in vitro at a ratio of 7,500 particles per cell for 2 h. Media alone, without particles in suspension, was also incubated with the melanoma cells for comparison. Cells were irradiated at 808 nm at 35 W/cm 2 for 3 min and later stained with calcein AM and ethidium homodimer-1 to indicate areas of live and dead cells respectively by fl uorescence microscopy. For cells incubated with Gd-NS before NIR laser exposure, viability staining depicted an area of dead cells corresponding to the irradiation zone. By comparison, irradiated cells without nanoshells remained viable, indicating that NIR light by itself is benign. Suffi cient heating to kills cells was only achieved where the NIR light and particles were combined locally, a fi nding in accordance with photothermal conversion studies and previously published work on the gold-silica nanoshell platform. [ 1 ] Finally, non-irradiated cells exposed to Gd-NS or media alone remained viable in either case, indicating that the particles alone were harmless to the cells.
Additionally, Gd-NS demonstrated effective contrast enhancement in an animal model with MRI, X-ray, and optical methods. After an intratumoral injection of Gd-NS (50 μ L at 6.3 × 10 12 NS/mL) in a subcutaneous B16-F10 melanoma tumor in a mouse, higher signal intensity was observed Maximum temperature values after a 3 min irradiation period at 808 nm are displayed for nanoshells in water at three different concentrations (OD 800 = 1, 2, and 4, corresponding to 0.25, 0.5, and 1 × 10 10 particles/mL respectively). Laser power was also varied at 1.25, 2.5, and 5 W. Water alone was used as a control and shows minimal heating above room temperature ( ∼ 22 °C) at all powers tested. All particle concentration/laser power combinations are signifi cantly different from others and water control, p < 0.05 by ANOVA and post hoc Tukey HSD, n = 3. Error bars indicate standard deviation.
in tumor tissue with particles under both T 1 -MRI and X-ray ( Figure 7 ) . As with the agarose phantoms, the entire tumor was imageable in the context of the mouse anatomy with each of these modalities. Tumor tissue was then harvested and imaged ex vivo with OCT, RCM, and TPL imaging modes. In the case of OCT, the highest signal intensities overall were observed within a few hundred microns of the tumor surfaces ( Figure 8 ). Within the fi rst 250 μ m, tumor tissue with nanoshells demonstrated 31.5% higher intensity than that of tumor tissue without particles (Figure 8 C) . Both RCM and TPL enabled further microscopic imaging, which exhibited readily apparent contrast enhancement in tumor tissue with Gd-NS compared to the control tissue without nanoshells ( Figure 9 ). Furthermore, as similarly seen in the agarose phantoms, individual particles could be resolved with TPL imaging at high magnifi cation.
. Conclusion
In summary, we have successfully tethered gadolinium to near-infrared resonant gold-silica nanoshells, imparting high r 1 relaxivity. These nanoshell conjugates subsequently afford contrast enhancement across a range of diagnostic modalities, with resolutions spanning anatomic to sub-cellular length scales, thus facilitating application for image-guided photothermal therapy. MRI and X-ray based modalities with gadolinium-nanoshell enhancement could be used to initially identify suspicious lesions within tissue. Afterwards, optical imaging with low-power NIR light could then be performed within appropriate fi elds of view to obtain molecular information regarding disease state. Such optical modes include OCT, RCM, and TPL, which all exhibit increased signal intensities with the addition of gadolinium-nanoshells. Finally, if therapy is deemed necessary, higher-powered NIR light can then be applied site-specifically to locally ablate disease, leaving surrounding normal tissue unharmed.
While the methods herein were applied to a superfi cial melanoma tumor model for initial proof-of-concept, these techniques could also be employed for more deep-seated tumors. With unlimited penetration depths through tissue, MRI and X-ray based modes have routinely been used for visualizing embedded anatomies. However, imageable depths for the optical methods described here are confi ned to the order of several hundred microns to millimeters. At the same time, recent developments in microendoscopy and fi ber bundle design are enabling access and administration of light to deep tissue. [ 31 ] Beyond their current broad utility, gadolinium-nanoshells offer a platform technology with potential for additional functionality and complexity. For instance, with the incorporation of targeting ligands, such as peptides, proteins, or nucleic acid based aptamers, gadolinium-nanoshells could home to desired receptors or molecular markers on diseased cells. These methods may provide more information regarding molecular phenotypes, which can be useful in characterizing disease and predicting invasiveness. [ 32, 33 ] 
. Experimental Section
Gold-Silica Nanoshell Synthesis : All glassware used in nanoparticle synthesis was cleaned with aqua regia (75% 12 N hydrochloric acid and 25% 16 N nitric acid by volume) followed by thorough rinsing with ultrapure water. Gold-silica shell-core nanoshells were synthesized via a seed-mediated growth process as described previously by Oldenburg et al. [ 9 ] Silica nanoparticles ∼ 120 nm in diameter (Precision Colloid) were coated with positively charged amine groups using 3-aminopropyl triethoxy silane (APTES, Gelest). Negatively charged colloidal gold ∼ 3-5 nm in size and synthesized according to methods by Duff et al. [ 34 ] was then adsorbed onto the aminated silica particles. These small gold particles served as nucleation sites for the formation of the thin gold shell over the silica core in the fi nal reduction reaction with chloroauric acid (HAuCl 4 , Alfa Aesar, 99.999%) and formaldehyde (HCHO, 37%). The gold-silica nanoshell product demonstrated peak extinction at ∼ 800 nm by UV-vis spectroscopy (Cary 50 Bio) and an average diameter of 152 ± 10 nm by transmission electron microscopy (TEM, JEOL 1230, Figure 1 ). Nanoshells were stored in 1.8 mM K 2 CO 3 at 4 °C until the conjugation reactions below were performed. Both the Beer-Lambert law and Mie theory were employed to determine nanoshell concentration as described elsewhere. [35] [36] [37] [38] OPSS-PEG-DOTA Synthesis : Chelated gadolinium ions were tethered to nanoshell surfaces with an orthopyridyl disulfi depoly(ethylene glycol)-succinimidyl propionate linker (OPSS-PEG-SPA, Nektar Therapeutics, MW = 2000 Da). The PEG linker was fi rst conjugated to an aminated gadolinium chelator, tetraazacyclododecane tetraacetic acid (DOTA) (2-aminoethyl-mono-amide-DOTAtris(t-Bu ester), Macrocyclics). To perform this reaction, the DOTA derivative (1.5 mmol) was added to anyhydrous N,N -dimethylformamide (DMF, Sigma Aldrich, 99.8%, 6 mL) followed by N,N -diisopropylethylamine (DIPEA, Sigma Aldrich, 99.5%, 3 mmol) in an amber glass vial, and the mixture was vortexed for 1 min to ensure complete dissolution. Next, OPSS-PEG-SPA (0.15 mmol) was added to achieve a 10:1 DOTA:PEG molar ratio. The vial was quickly purged with ultra high purity nitrogen gas, capped, vortexed for an additional 1 min, and then rocked overnight at room temperature. The next day, the sample was diluted 1:4 with ice-cold ultrapure water and then transferred to a regenerated cellulose dialysis membrane (Spectrum Laboratories, MWCO = 2000 Da). The sample was dialyzed against ultrapure water followed by lyophilization. To deprotect the -COOH groups on the DOTA derivative, the lyophilized product was added to an amber glass vial followed by dichloromethane (DCM, EMD Millipore OmniSolv, 4.18 mL) and trifl uoroacetic acid (TFA, J.T. Baker, 2.61 mL). The vial was then purged with ultra high purity nitrogen, capped, and left to rock overnight at room temperature. The next day, the solvent was removed by rotary evaporation (Büchi Rotavapor R-200, 40 °C, 200 mbar) over approximately 10 min. The residual solid was washed three times with ethyl ether (EMD, OmniSolv, 100 mL) prechilled to 4 °C while decanting the ethyl ether after each wash. After air drying the solid at room temperature for 4 h, the product was dissolved in ultrapure water, dialyzed against ultrapure water (2000 MWCO regenerated cellulose, Spectrum Laboratories), lyophilized, and then stored at −20 °C until further use. Over 90% of the PEG linker was found to be conjugated to the gadolinium chelator as determined by gel permeation chromatography (GPC, Agilent Technologies, PLgel 5 μ m 500 Å column with PL ELS 1000 detector, Figure S1 ).
Gadolinium Chelation to form OPSS-PEG-Gd(DOTA)
: A gadolinium chelation reaction with methods adapted from Ratzinger et al. [ 22 ] and Sosabowski and Mather [ 23 ] was performed. First, a single solution at 200 mM gadolinium(III) chloride hexahydrate (GdCl 3 •6H 2 O, Sigma Aldrich, 99%) and 600 mM citric acid was made with ultrapure H 2 O and adjusted to pH 8 with sodium hydroxide (NaOH). The gadolinium-citric acid solution (10 mL) was added to OPSS-PEG-DOTA (70 mg) in a glass vial to achieve a Gd:DOTA molar ratio of approximately 70:1. The vial was rocked for 48 h at 37 °C to facilitate metalation. Excess gadolinium was removed by dialysis against 100 mM sodium citrate followed by ultrapure water. The retentate was recovered, lyophilized, and stored at −20 °C until further use. Successful chelation was confi rmed by inductively coupled plasma optical emission spectrometry (ICP-OES, Perkin Elmer Optima 4300 DV), after dissolving the solid OPSS-PEG-Gd(DOTA) in pure aqua regia overnight. Samples were then diluted with 1% aqua regia. With the analyte wavelength set to 342 nm for gadolinium and yttrium as the chemical reference at 371 nm, gadolinium content was calculated to be ∼ 0.082 g Gd/g OPSS-PEG-Gd(DOTA). Further characterization of OPSS-PEG-Gd(DOTA) and OPSS-PEG-DOTA in deteurium oxide (D 2 O) was performed with proton nuclear magnetic resonance spectroscopy (NMR, Varian, 400 MHz); these results are outlined in the Supporting Information ( Figure S2 ).
OPSS-PEG-Gd(DOTA) Conjugation to Nanoshells
: To tether chelated gadolinium to gold-silica nanoshells, the particles were fi rst suspended in ultrapure water (180 mL) at a concentration of ∼ 4.0 × 10 9 particles/mL. OPSS-PEG-Gd(DOTA) (2 mL) at a concentration of 600 μ g/mL in ultrapure water was added to the nanoshell suspension, which was then mixed for 1 h at 4 °C. Remaining gold surface area on the particles was then backfi lled with poly(ethylene glycol)-thiol (PEG-SH, Laysan Bio, MW = 5000 Da) by addition of 10 μ M PEG-SH (20 mL) in ultrapure water and further mixing of the nanoshell suspension overnight at 4 °C. Gold-silica nanoshells conjugated to PEG-SH only (without any addition of OPSS-PEGGd(DOTA)) were also prepared as a control for relaxometry characterization and imaging experiments to follow. Three rounds of centrifugation were performed to concentrate the particles and remove unreacted molecules. Nanoshell conjugates were stored at 4 °C until further use. To quantify the degree of gadolinium conjugation, elemental analysis was performed with inductively coupled plasma mass spectrometry (ICP-MS, Perkin Elmer ELAN 9000). After overnight digestion with pure aqua regia and dilution with 1% aqua regia, gadolinium-nanoshells (Gd-NS) were calculated to have an average of 3.5 × 10 4 Gd ions per nanoshell ( n = 3). Additionally, unconjugated gadolinium was found to constitute approximately 0.1% of the total gadolinium content by ICP-MS analysis on the supernatant collected after the fi nal round of centrifugation, indicating that the purifi cation procedure was successful.
Dynamic Light Scattering and Zeta Potential Characterization : Following nanoshell conjugation, characterization of hydrodynamic diameter and zeta potential was performed with a Malvern Zen 3600 Zetasizer. Gadolinium-nanoshells were dispersed in ultrapure water and measurements were acquired in triplicate. Both PEG-nanoshells and unconjugated nanoshells were analyzed for comparison. Table 1 in Supporting Information displays these results.
Relaxometry Characterization : T 1 relaxation times of Gd-NS were acquired with a benchtop relaxometer (Bruker Minispec mq60, 1.41 T, 37 °C) and compared to that of PEG-nanoshells (PEG-NS), OPSS-PEG-Gd(DOTA), and ultrapure water as controls. Measurements ( n = 6) were taken with Gd-NS in water at fi ve concentrations (8.6, 4.3, 2.2, 1.1, and 0.5 × 10 11 nanoshells/mL) corresponding to gadolinium concentrations of 50, 25, 13, 6, and 3 μ M. PEG-NS and OPSS-PEG-Gd(DOTA) in water at equivalent nanoshell and gadolinium concentrations, respectively, were also analyzed. All samples (200 μ l at room temperature) were thermostated to the magnet temperature by inserting them into the instrument and waiting 2 min before data acquisition.
Evaluation of Cytotoxicity : Cytotoxicity of the gadoliniumnanoshells was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. HepG2 hepatocellular carcinoma cells (ATCC) and human dermal fi broblasts (HDF, Lonza) were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 U/L penicillin, and 100 mg/L streptomycin and maintained at 37 °C in a 5% CO 2 incubator. HepG2 cells were seeded into tissue culture-treated, 96-well plates at 9000 cells/well. For HDF cells, a lower seeding density of 4500 cells/well was used because the fi broblasts are larger in size than HepG2 cells. Cells were then allowed to adhere overnight. The next day, the culture medium was removed, and 130 μ L fresh medium was added with Gd-NS in suspension to achieve particle-to-cell ratios of 3750, 7500, and 15 000. PEG-nanoshells as well as cell only samples without any particles were included for comparison. All conditions were tested in triplicate. After incubating cells with the particles for 24 h and 48 h, 26 μ L MTS reagent (Promega) was added to all wells. Following a 1 h incubation period at 37 °C and 5% CO 2 , media samples were transferred to microcentrifuge tubes and then centrifuged at 735 g for 5 min to completely pellet any nanoparticles in suspension. 100 μ l of supernatant was then transferred to a new 96-well plate, and the optical density at 490 nm was measured with a plate reader. Cell viability was then determined with the average OD 490 value for each treatment as a percent of the average OD 490 for the cell only control condition.
Agarose Phantom Synthesis : Gd-NS (100 μ L) in water at 8.6 × 10 11 particles/mL were combined with 2% agarose (Sigma Aldrich, 100 μ L) in preheated, ultrapure water to ensure complete dissolution of the agarose. Samples were quickly mixed in a small glass vial by gentle vortexing and then chilled at 4 °C to solidify. Agarose phantoms containing PEG-NS were prepared similarly in addition to 1% agarose phantoms without nanoshells as controls.
In Vitro Phantom Imaging : Agarose phantoms were imaged with fi ve imaging modalities: T 1 -weight magnetic resonance imaging (MRI), X-ray, optical coherence tomography (OCT), refl ectance confocal microscopy (RCM), and two-photon luminescence (TPL). MRI was performed with a 3 T clinical scanner (Philips Ingenia) with an inversion recovery pulse sequence ( TR = 3000 ms, TE = 15 ms, IR = 875 ms). X-ray imaging was conducted using a Kubtec XPERT80 radiography system with the radiation source set to 27 kV and 850 μ A. For OCT imaging, a Niris Imalux system was used with a laser operating at a wavelength of 1310 nm and power of 3 mW. A fi ber optic probe connected to the laser source was placed in contact with the tissue phantom for imaging. For RCM, a Lucid-Tech VivaScope 2500 confi gured with an 840 nm laser at 0.375 mW and a 20× objective was used. Agarose phantoms were placed on glass slides with water between the phantom and glass slide and ultrasound gel between the slide and objective as index matchers. Images were acquired at 32 μ m depths. For TPL, a Zeiss Laser Scannning Microscope (LSM) 510 META with a femtosecond-pulsed Ti:sapphire laser (Chameleon) was used. With an output power of ∼ 1 mW, the laser was set to 810 nm to excite nanoshells at their plasmon resonant wavelength while the META detector was confi gured to collect twophoton luminescence from 450 to 650 nm. Images of phantoms on coverglass were acquired with a 20X objective and 63X immersion oil objective at 20 and 5 μ m depths, respectively.
Photothermal Conversion : Both Gd-NS and PEG-NS at three concentrations (10, 5, and 2.5 × 10 9 particles/mL) in water were irradiated within disposable cuvettes with an FAP-1 diode laser (Coherent) at 808 nm, which coincided with the plasmon resonant wavelength of the nanoshells. Maximum temperature values of the nanoshell suspensions ( n = 3) were acquired with a thermocouple (Omegaette HH5500 Temperature Recorder) after three minutes of irradiation at three laser power settings (1.25, 2.5, and 5 W). Water without nanoshells was also used as a control.
In Vitro Photothermal Ablation : B16-F10 melanoma cells (ATCC) were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 U/L penicillin, and 100 mg/L streptomycin and maintained at 37 °C in a 5% CO 2 incubator. 300,000 B16-F10 melanoma cells per well were seeded into 4-well chamber glass slides and allowed to adhere overnight. After aspiration of the cell culture medium the next day, 500 μ L of Gd-NS in DMEM (4.5 × 10 9 particles/mL) was added to the cells for a ratio of 7500 particles per seeded cell. DMEM without particles was used as a control. The melanoma cells were then incubated at 37 °C in 5% CO 2 for 2 h, during which time the nanoshells settled onto cell surfaces. Following removal of the medium, 200 μ L 1X phosphate buffered saline (PBS) was gently added to the cells. Next, cells were irradiated at 808 nm and 35 W/cm 2 for 3 min, using the same laser system employed in the photothermal conversion study. Non-irradiated cells incubated with or without Gd-NS were also included for comparison. The PBS was then replaced with DMEM medium, and the cells were incubated at 37 °C in 5% CO 2 for 4 h to allow ample time for completion of cell death in response to therapeutic heating. Viability staining was then performed according to manufacturer's instructions, using calcein AM and ethidium homodimer-1 (Invitrogen). Samples were then imaged under fl uorescence microscopy with an inverted Zeiss Axiovert 135 microscope (calcein excitation/emission: 480/535 nm; ethidium homodimer-1 excitation/emission: 560/645 nm).
Animal Tumor Model : B16-F10 cells (1 × 10 6 in 200 μ l PBS) were injected subcutaneously into the right fl ank of 12-week old male Nude mice (Nu/Nu, Charles River). Mice were kept on a 12 h light-dark cycle with food and water ad libitum . All animal experiments were approved by the Institutional Animal Care & Use Committee (IACUC) of The Methodist Hospital Research Institute and performed in accordance with the institutional guidelines on the ethical use of animals.
Animal Imaging with MRI and X-Ray : Animal imaging experiments were performed 10 -15 days after B16-F10 cell implantation, once tumors had reached ∼ 1 cm in diameter. In one mouse, nanoshell suspension (50 μ l at 6.3 × 10 12 Gd-NS/mL) was injected intratumorally, and the animal was sacrifi ced immediately post injection. T 1 -weighted MR images were acquired with a 3 T clinical scanner (Philips Ingenia) using a spin echo sequence ( TR = 500 -700 ms, TE = 23 ms, slice thickness = 500 μ m). As a control, a tumored mouse without injected nanoshells was imaged as well at the same settings. For X-ray imaging, animals were imaged as with the agarose tissue phantoms described above, using the Kubtec XPERT-80 radiography system.
Tumor Tissue Optical Imaging Ex Vivo : For optical imaging experiments, the B16-F10 melanoma tumors were resected from the fl anks of the mice. The tumors were then sectioned in half along the midline, using a scalpel, and imaging was conducted within the tumor interior. For OCT imaging, a Niris Imalux system similar to the setup described above was employed. Here, a 1310 ± 15 nm laser at 3 mW was used and confi gured with a fi ber optic probe, which was kept ∼ 1 mm above the tumor surface during imaging. After image acquisition, intensity profi le analysis with NIH ImageJ software was performed to determine differences in signal intensities between tumor tissue with and without nanoparticles. For each group, a total of 30 profi les with pixel intensity values across 250 μ m beneath the tumor surface were acquired. The mean intensity was then calculated by normalizing and averaging all pixel intensity values ( n = 1530) within the profi les. For RCM and TPL imaging of the tumor tissue, the same imaging setups and associated parameters were used as with the agarose tissue phantoms described above.
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